ERIC SPRONZ: Open Payments
NPI 1922332261 · CENTEREACH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109,075 in 259 payments from 15 companies in 2025. Trend: 2023 $110,510 · 2024 $76,798 · 2025 $109,075
Speaker / faculty: $84,116Travel & lodging: $10,270Consulting: $9,115Food & beverage: $5,377Honoraria: $150Education: $47
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 149 | $93,424 |
| Otsuka America Pharmaceutical, Inc. | 20 | $5,057 |
| E.R. Squibb & Sons, L.L.C. | 24 | $4,771 |
| ABBVIE INC. | 24 | $4,509 |
| Axsome Therapeutics, Inc. | 8 | $265 |
| ACADIA Pharmaceuticals Inc | 5 | $198 |
| H2-Pharma, LLC | 1 | $150 |
| Lundbeck LLC | 8 | $136 |
| Vanda Pharmaceuticals Inc. | 4 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
Products named: INGREZZA, REXULTI, VRAYLAR, COBENFY, NUPLAZID, Sunosi, SPRAVATO, Auvelity.
Industry payments across NY — which companies pay providers there.
